Helvetica Pharma Distribution SPRL

Helvetica Pharma Distribution reported total assets of 589 € at the end of the 2024 financial year (annual accounts filed with the NBB on 03 Dec 2024).

Company number (CBE) 0833.820.710 · VAT BE0833820710
1050 Ixelles
active in Activities of agents involved in non-specialised wholesale (NACE 46190)
operating since 17 Feb 2011 (≈ 15 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Helvetica Pharma Distribution shows with a free account.

See the score
Profile
SPRL since 2011
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2024

Net result−778 €
Equity−385,571 €
Cash589 €
EBITDA−366 €
Total assets589 €

Change 2021 → 2024: Total assets -91 %

Accounts of the company itself (not consolidated).

The full file covers 9 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Helvetica Pharma Distribution's annual accounts

20242023202220212020
Net result−778 €
Equity−385,571 €
Cash589 €
EBITDA−366 €
Total assets589 €

Filed annual accounts

  • Year ended 30 Jun 2024filed on 03 Dec 2024
  • Year ended 30 Jun 2023filed on 30 Nov 2023
  • Year ended 30 Jun 2022filed on 15 Dec 2022
  • Year ended 30 Jun 2021filed on 29 Nov 2021
  • Year ended 30 Jun 2020filed on 25 Nov 2020

Helvetica Pharma Distribution's financial analysis

Management and control of Helvetica Pharma Distribution

2 active director(s) in the register.

Helvetica Pharma Distribution's shareholders and holdings →

Helvetica Pharma Distribution's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0833.820.710
VAT number
BE0833820710
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SPRL
Incorporated
17 Feb 2011
Registered office
1050 Ixelles
Latest accounts
2024 · filed on 03 Dec 2024
Activity
Activities of agents involved in non-specialised wholesale (NACE 46190)

Helvetica Pharma Distribution (SPRL) has been based in Ixelles since 2011, active in: activities of agents involved in non-specialised wholesale. For 2024, it reports a net loss of 778 € and equity of −385,571 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Helvetica Pharma Distribution

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Helvetica Pharma Distribution

What is the revenue of Helvetica Pharma Distribution?

Helvetica Pharma Distribution files its accounts in a format where revenue is optional: it is not published for 2024.

What is the VAT number of Helvetica Pharma Distribution?

In Belgium, the VAT number is the company number prefixed with BE: BE0833820710 for Helvetica Pharma Distribution, if the company is VAT-registered. Its company number (CBE) is 0833.820.710.

Where is the registered office of Helvetica Pharma Distribution?

According to the CBE register, the registered office of Helvetica Pharma Distribution is in 1050 Ixelles.

Who manages Helvetica Pharma Distribution?

The register lists 2 active mandates at Helvetica Pharma Distribution. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Helvetica Pharma Distribution

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 28 Aug 2026

No credit card, no commitment.

What each plan unlocks →